Camber Pharmaceuticals Recalls Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, Nationwide.

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)

 

For Immediate Release

February 28, 2019

Contact

Consumers

Camber Pharmaceuticals’ Med Line
 1-866-495-1995

Media

Stericycle Customer Service
Recalls – Event 4862
 Camber4862@stericycle.com
 1-888-275-0506

Announcement

Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).

NMBA is a potential human carcinogen. To date, Camber has not received any reports of adverse events related to this recall.

Losartan Potassium, USP, is a prescription medication used to treat high blood pressure and congestive heart failure and is packaged in 30ct, 90ct, 500ct, 1000ct bottles. The identifying NDC #s associated with Camber’s product as are follows: Losartan 25 mg 31722-700-90, 31722-700-05, 31722-700-10; Losartan 50 mg 31722-701-30, 31722-701-90, 31722-70-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10.

The affected Losartan includes 87 lot numbers which are listed below:

NDC	Name and Strength	Count	Lot#	Expiry
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17026B	Sep-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17050	Sep-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17051	Sep-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17052	Sep-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17053	Sep-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP17061	Oct-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP18035	Dec-19
31722-700-90	Losartan Potassium Tablets USP 25 mg	90	LOP18036	Dec-19
31722-700-05	Losartan Potassium Tablets USP 25 mg	500	LOP17026	Sep-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP17006	May-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP17025	Sep-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP17068	Oct-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP18037	Dec-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP18038	Dec-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP18039	Dec-19
31722-700-10	Losartan Potassium Tablets USP 25 mg	1000	LOP18057	Jan-20
31722-701-30	Losartan Potassium Tablets USP 50 mg	30	LOP17028C	Sep-19
31722-701-30	Losartan Potassium Tablets USP 50 mg	30	LOP17064A	Nov-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17027	Sep-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17063	Nov-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17093	Nov-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17094	Dec-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17095	Dec-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17097A	Dec-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17105	Dec-19
31722-701-90	Losartan Potassium Tablets USP 50 mg	90	LOP17107	Dec-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17004	Dec-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17028B	Sep-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17048	Oct-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17049	Oct-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17056	Nov-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17073	Nov-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17074	Nov-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17076	Nov-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP17096	Dec-19
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18077A	Feb-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18078	Feb-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18079	Feb-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18080	Feb-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18081	Mar-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18084	Mar-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18095	Mar-20
31722-701-10	Losartan Potassium Tablets USP 50 mg	1000	LOP18096	Mar-20
31722-702-30	Losartan Potassium Tablets USP 100 mg	30	LOP17011	Aug-19
31722-702-30	Losartan Potassium Tablets USP 100 mg	30	LOP17087	Nov-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17012	Aug-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17013	Aug-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17042	Oct-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17043	Oct-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17044	Nov-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP17045	Nov-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18024	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18025	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18026	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18027	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18028	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18029	Dec-19
31722-702-90	Losartan Potassium Tablets USP 100 mg	90	LOP18030	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17005	May-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17014	Aug-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17016	Sep-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17023	Sep-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17083	Oct-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17084	Nov-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17085	Nov-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP17086	Nov-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18021	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18022	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18023	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18031	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18032	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18033	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18050	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18051	Dec-19
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18109	Mar-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18111	Mar-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18122	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18123	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18124	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18125	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18126	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18127	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18128	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18129	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18130	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18131C	Jun-20
31722-702-10	Losartan Potassium Tablets USP 100 mg	1000	LOP18133	Jun-20

Losartan Potassium Tablets were distributed Nationwide to Wholesalers, Distributors, Retail Pharmacies, and Mail Order Pharmacies.

Stericycle is notifying Camber’s distributors and other customers by recall letter and arranging for return of recalled product of Losartan Potassium Tablets.

Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking the product. Pharmacies and healthcare facilities that have the product being recalled should stop using and dispensing the product immediately.

Consumers with questions regarding this recall can contact Camber Pharmaceuticals’ Med Line at 1-866-495-1995 Monday – Friday, 9am – 5pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch

Adverse reactions or quality problems associated with the use of this product may be reported to FDA's MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

This recall is being conducted with the knowledge of the U.S. Food and Drug administration.

###

 

AurobindoPharma USA Expands The Recall Of Amlodipine Valsartan Tablets USP and Valsartan Tablets

AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 38 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity.

 

For Immediate Release

March 1, 2019

Contact

Consumers

AurobindoPharma USA, Inc.
  pvg@aurobindousa.com
 1-866-850-2876 Option 2

Media

Inmar\CLS-Medturn
  aurobindorecalls@inmar.com 
 1-877-208-2407

Announcement

AurobindoPharma USA, Inc. is conducting a voluntary recall expansion of 38 lots of Valsartan and Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug producAurobindoPharma USA, Inc. is conducting a voluntary recall expansion of 38 lots of Valsartan and Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. This recall is an expansion of the recall initiated 12/31/18 The impurity detected in the finished drug product is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. The expansion relates to lots distributed under the labels for AurobindoPharma USA, Inc. and Acetris Health, LLC.  To date, AurobindoPharma USA, Inc. has not received any reports of adverse events related to this recall.

Amlodipine Valsartan Tablets USP and Valsartan Tablets USP are indicated to control high blood pressure and for the treatment of heart failure. Patients who prescribed Amlodipine Valsartan Tablets USP and Valsartan Tablets USP should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.

The products subject to recall are listed below and packaged in bottles. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products.

NDC	Name and strength	Count	Lot number	Expiry
ACETRIS LOTS
52343-122-30	Valsartan Tablets USP 40mg	30	470170038A	19-Oct
52343-122-30	Valsartan Tablets USP 40mg	30	470180010A	20-Feb
52343-122-30	Valsartan Tablets USP 40mg	30	470180012A	20-Mar
52343-123-90	Valsartan Tablets USP 80mg	90	471170019A	19-Oct
52343-123-90	Valsartan Tablets USP 80mg	90	471180006A	20-Mar
52343-123-90	Valsartan Tablets USP 80mg	90	471180007A	20-Mar
52343-123-90	Valsartan Tablets USP 80mg	90	471180016A	20-May
52343-124-90	Valsartan Tablets USP 160mg	90	472180005B	20-Feb
52343-124-90	Valsartan Tablets USP 160mg	90	472180011A	20-Apr
52343-124-90	Valsartan Tablets USP 160mg	90	472180012A	20-Apr
52343-125-90	Valsartan Tablets USP 320mg	90	473180007A	20-Mar
52343-125-90	Valsartan Tablets USP 320mg	90	473180008A	20-Mar
52343-125-90	Valsartan Tablets USP 320mg	90	473180011A	20-Apr
52343-125-90	Valsartan Tablets, USP 320mg	90	473180020B1	20-Jul
AUROBINDO LOTS
65862-570-30	Valsartan Tablets USP 40mg	30	470180008A	20-Feb
65862-570-30	Valsartan Tablets USP 40mg	30	470180014A	20-Mar
65862-570-30	Valsartan Tablets USP 40mg	30	470180016A	20-Mar
65862-571-90	Valsartan Tablets USP 80mg	90	471170015A	19-Sep
65862-571-90	Valsartan Tablets USP 80mg	90	471180004A	20-Feb
65862-571-90	Valsartan Tablets USP 80mg	90	471180005A	20-Feb
65862-572-90	Valsartan Tablets USP 160mg	90	472180001A	20-Jan
65862-572-90	Valsartan Tablets USP 160mg	90	472180002A	20-Jan
65862-572-90	Valsartan Tablets USP 160mg	90	472180003A	20-Jan
65862-572-90	Valsartan Tablets USP 160mg	90	472180004A	20-Jan
65862-572-90	Valsartan Tablets USP 160mg	90	472180007A	20-Mar
65862-572-90	Valsartan Tablets USP 160mg	90	472180008A	20-Mar
65862-572-90	Valsartan Tablets USP 160mg	90	472180009A	20-Mar
65862-572-90	Valsartan Tablets USP 160mg	90	472180010A	20-Mar
65862-572-90	Valsartan Tablets USP 160mg	90	472180013A	20-Apr
65862-572-90	Valsartan Tablets USP 160mg	90	472180014A	20-Apr
65862-573-90	Valsartan Tablets USP 320mg	90	473180004A	20-Feb
65862-573-90	Valsartan Tablets USP 320mg	90	473180005A	20-Feb
65862-573-90	Valsartan Tablets USP 320mg	90	473180006A	20-Mar
65862-573-90	Valsartan Tablets USP 320mg	90	473180017A	20-May
65862-739-30	Amlodipine and Valsartan Tablets USP10mg/160mg	30	VFSA17007-A	19-Oct
65862-570-30	Valsartan Tablets, USP 40mg	30	470180032A	20-May
65862-573-90	Valsartan Tablets, USP 320mg	90	473170019A	19-Oct
65862-573-90	Valsartan Tablets, USP 320mg	90	473180016A	20-May

Amlodipine Valsartan Tablets USP and Valsartan Tablets USP were distributed nationwide to AurobindoPharma USA, Inc. and Aceteris Health LLC wholesale, distributor, repackager and retail customers. AurobindoPharma USA, Inc. is notifying its distributors and customers by phone and in writing to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. AurobindoPharma USA, Inc. is arranging for return of all recalled products to Inmar. Instructions for returning recalled products are given in the recall letter.

Consumers with medical questions regarding this recall or to report an adverse event can contact AurobindoPharma USA, Inc. at:

• 1-866-850-2876 Option 2
• pvg@aurobindousa.com

Consumers should also contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Any general questions regarding the return of this product please contact Inmar\CLS-Medturn at 1-877-208-2407 or email aurobindorecalls@inmar.com  (live calls received 9 am -5:00 pm Eastern Time).

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm Call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

###

•  
•  
•  
•  
•  
•  
•  
•  
• 

 

Clinical Resolution Laboratory Recalls Numb 100 Topical Anesthetic Cream

Name of product:

Numb 100 Topical Anesthetic Cream

Hazard:

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.

Remedy:

Refund

Replace

Recall date:

February 28, 2019

Units:

26,500

Consumer Contact:

Clinical Resolution Laboratory toll-free at 877-566-9687 from 8 a.m. to 5 p.m. PT Monday to Friday, email at info@clinicalresolution.com or online at www.clinicalresolution.com and click on the Recall Information tab at the top of the page for more information.

Recall Details

Description:

This recall involves Numb 100 Topical Anesthetic Cream. The recalled cream is in a 1.35 fluid ounce white jar with a rounded cap. Numb 100 Topical Anesthetic Cream and a blue cross are printed on the jar’s front panel.

 

Remedy:

Consumers should immediately place the recalled topical anesthetic out of reach of children and contact Clinical Resolution Laboratory for a full refund, a free replacement cream, or free replacement child-resistant cap.

Incidents/Injuries:

None reported

Sold At:

Laser Jet and other health and beauty stores nationwide and online at www.amazon.com and www.laserjetinc.com from May 2017 through November 2018 for about $18.

Manufacturer(s):

Clinical Resolution Laboratory, Inc. of Brea, Calif.

Distributor(s):

Laser Jet, Inc. of Brooklyn, N.Y.

Manufactured In:

United States

Recall number:

19-076

 

Biotouch Recalls EZY Gel Topical Anesthetic Gel

Name of product:

EZY Gel Topical Anesthetic Gel

Hazard:

The package is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving gel contains lidocaine, posing a risk of poisoning to young children.

Remedy:

Refund

Recall date:

February 28, 2019

Units:

About 8,500

Consumer Contact:

Biotouch toll-free at 844-557-9023 from 10 a.m. to 4 p.m. PT Monday through Friday, email at recall@biotouch.com , or online at www.biotouch.com and click on Recall at the bottom of the page for more information.

Recall Details

Description:

This recall involves EZY Gel Topical Anesthetic Gel. The recalled product was sold in 1 fluid ounce white bottles. Biotouch Topical Anesthetic Gel EZY Gel is printed on a purple label located on the front panel. Lot numbers and expiration dates are located on the bottom of the bottle.

 

Remedy:

Consumers should immediately place the recalled topical anesthetic out of reach of children and contact Biotouch for instructions on how to obtain a full refund, including shipping.

Incidents/Injuries:

None reported

Sold At:

Biotouch stores, beauty suppliers and tattoo salons nationwide and online at www.amazon.com, www.biotouch.com, www.ebay.com, www.jet.com or www.walmart.com from August 2013 through August 2018 for about $60

Manufacturer(s):

Biotouch Inc., of City of Industry, Calif.

Distributor(s):

Adventiz Inc. of Chino Hills, Calif. (Online)

Recall number:

19-075

 

Harbor Freight Tools Recalls Propane Torches

Name of product:

Greenwood propane torches

Hazard:

The trigger on the torches that engages the flame can fail to disengage when the trigger is no longer pressed, posing a burn hazard.

Remedy:

Replace

Recall date:

February 27, 2019

Units:

About 150,000

 

Consumer Contact:

Harbor Freight Tools at 800-444-3353 Monday through Friday from 8 a.m. to 4:30 p.m. PT, email at recall@harborfreight.com or online at www.harborfreight.com and click on Recall Safety Information on the bottom of the homepage for more information. 

Recall Details

Description:

This recall involves two models of the Greenwood-branded propane torches. The torches with no igniter have SKU number 61589 and the torches with a push button igniter have SKU number 61595. The torches have a steel nozzle, a flow valve, a blue grip and a black or orange hose. The SKU number is printed on a sticker located on the pipe that leads to the nozzle on the product packaging and on the manual. Only propane torches that do not have markings on the handles or brass knobs are included in this recall. ​​

 

Remedy:

Consumers should immediately stop using the recalled torches and return them to any Harbor Freight Tools location for a free replacement propane torch.

Incidents/Injuries:

Harbor Freight has received two reports of the trigger failing to disengage, including one report of a burn injury.

Sold Exclusively At:

Harbor Freight Tools stores nationwide and online at www.harborfreight.com from November 2013 through October 2018 for between $20 and $30.

Importer(s):

Harbor Freight Tools, of Calabasas, Calif.

Distributor(s):

Harbor Freight Tools, of Calabasas, Calif.

Manufactured In:

China

Recall number:

19-074

 

Harbor Freight Tools Recalls 12V Rechargeable Flashlights

  Product:
  Rechargeable Flashlights

Hazard:

The flashlight can overheat while charging, posing a burn hazard to consumers.

Remedy:

Refund

Recall date:

February 27, 2019

Units:

About 500,000

Consumer Contact:

Harbor Freight Tools at 800-444-3353 from 8 a.m. to 4:30 p.m. PT Monday through Friday, email at recall@harborfreight.com or online at www.harborfreight.com and click on “Recall Safety Information” on the bottom of the homepage for more information.

Recall Details

Description:

This recall involves the Harbor Freight 80 Lumen 12v rechargeable flashlights.  The small black flashlight has a soft white button located on the side to turn the flashlight on and off. The base of the flashlight is a charger that fits into any standard vehicle 12V power port to charge. The recalled flashlight’s SKU number is 64109 and can be found on the sticker label that also bears the product barcode. The flashlight is approximately 5 inches long.

 

Remedy:

Consumers should immediately stop using the recalled flashlights, and return them to any Harbor Freight Tools location for a refund in the form of a $5 Harbor Freight Tools gift card.

Incidents/Injuries:

Harbor Freight Tools has received two reports of the flashlight overheating.  No reports of injury.

Sold Exclusively At:

Harbor Freight Tools stores nationwide from August 2018 through January 2019 for between $2 and $4.

Importer(s):

Harbor Freight Tools, of Calabasas, Calif.

Distributor(s):

Harbor Freight Tools, of Calabasas, Calif.

Manufactured In:

China

Recall number:

19-073